GlassScriptPhysician profile
Michael J Socher
NPI 1811056344
$1,379.83
in general payments reported to CMS, 2019-2025
15 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $57.20 · 2021: $168 · 2022: $414 · 2023: $538 · 2024: $29.46 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411 · Travel and Lodging: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.83 |
| Travel and Lodging | $330.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $370.67 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $209.59 | 2020-2023 | Lo Loestrin Fe, Orilissa |
| Organon LLC | $187.79 | 2022-2025 | Jada System |
| Daiichi Sankyo INC. | $173.18 | 2022-2023 | Injectafer |
| Eisai INC. | $125.01 | 2025 | |
| Sumitomo Pharma America, INC. | $83.15 | 2023-2025 | Gemtesa, Myfembree |
| Astellas Pharma US INC | $44.65 | 2023 | Myrbetriq, Veozah |
| Urovant Sciences INC | $41.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.61 | 2023 | |
| Merck Sharp & Dohme LLC | $29.08 | 2021 | |
| Myovant Sciences INC. | $24.60 | 2021 | |
| Therapeuticsmd, INC. | $14.63 | 2022 | |
| Hologic Sales and Service, LLC | $14.13 | 2021 | |
| Axonics, INC. | $12.47 | 2022 | |
| Avion Pharmaceuticals | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Socher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.